Your browser doesn't support javascript.
loading
Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease.
Zingone, Adriana; Wang, Weixin; Corrigan-Cummins, Meghan; Wu, S Peter; Plyler, Ryan; Korde, Neha; Kwok, Mary; Manasanch, Elisabet E; Tageja, Nishant; Bhutani, Manisha; Mulquin, Marcia; Zuchlinski, Diamond; Yancey, Mary Ann; Roschewski, Mark; Zhang, Yong; Roccaro, Aldo M; Ghobrial, Irene M; Calvo, Katherine R; Landgren, Ola.
Afiliação
  • Zingone A; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wang W; Hematology Service, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, USA.
  • Corrigan-Cummins M; Hematology Service, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, USA.
  • Wu SP; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Plyler R; Hematology Service, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, USA.
  • Korde N; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kwok M; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Manasanch EE; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Tageja N; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bhutani M; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Mulquin M; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zuchlinski D; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yancey MA; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Roschewski M; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zhang Y; Dana-Faber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.
  • Roccaro AM; Dana-Faber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.
  • Ghobrial IM; Dana-Faber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.
  • Calvo KR; Hematology Service, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, USA.
  • Landgren O; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: landgrec@mskcc.org.
Cytokine ; 69(2): 294-7, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25043675
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Quimiocinas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Progressão da Doença / Quimiocinas / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article